← Back to Clinical Trials
Recruiting NCT05022420
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
Trial Parameters
Condition Tolerance
Sponsor University Hospital, Brest
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-08-19
Completion 2025-02-18
All Conditions
Brief Summary
Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
Eligibility Criteria
Inclusion Criteria: * biospy required for the diagnsis or follow up aged of more than 18 non opposition form Exclusion Criteria: * unable to consent demencia unable to fill the form and questionnaire patient Under juridical protection refusing to participate